Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-054331
Filing Date
2025-04-15
Accepted
2025-04-15 17:30:04
Documents
1
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4006
  Complete submission text file 0000950170-25-054331.txt   5540
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Issuer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 LAKESIDE DRIVE FOSTER CITY X1 94404
Business Address
McHutchison John G (Reporting) CIK: 0001738125 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35005 | Film No.: 25840717